DK2086556T3 - Populationer af blandede celler til vævsreparation og separationsteknik til cellebehandling - Google Patents
Populationer af blandede celler til vævsreparation og separationsteknik til cellebehandlingInfo
- Publication number
- DK2086556T3 DK2086556T3 DK07867360.5T DK07867360T DK2086556T3 DK 2086556 T3 DK2086556 T3 DK 2086556T3 DK 07867360 T DK07867360 T DK 07867360T DK 2086556 T3 DK2086556 T3 DK 2086556T3
- Authority
- DK
- Denmark
- Prior art keywords
- biochamber
- cells
- enzyme
- rinse solution
- tissue repair
- Prior art date
Links
- 238000000926 separation method Methods 0.000 title 1
- 230000017423 tissue regeneration Effects 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 5
- 102000004190 Enzymes Human genes 0.000 abstract 4
- 108090000790 Enzymes Proteins 0.000 abstract 4
- 238000012258 culturing Methods 0.000 abstract 3
- 239000001963 growth medium Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000011072 cell harvest Methods 0.000 abstract 1
- 210000004748 cultured cell Anatomy 0.000 abstract 1
- 238000011534 incubation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0669—Bone marrow stromal cells; Whole bone marrow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85650406P | 2006-11-03 | 2006-11-03 | |
US93270207P | 2007-06-01 | 2007-06-01 | |
PCT/US2007/023302 WO2008054825A2 (en) | 2006-11-03 | 2007-11-05 | Mixed cell populations for tissue repair and separation technique for cell processing |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2086556T3 true DK2086556T3 (da) | 2011-05-09 |
Family
ID=39344931
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11150452.8T DK2314300T3 (da) | 2006-11-03 | 2007-11-05 | Populationer af blandede celler til vævsreparation og separationsteknik til cellebehandling |
DK07867360.5T DK2086556T3 (da) | 2006-11-03 | 2007-11-05 | Populationer af blandede celler til vævsreparation og separationsteknik til cellebehandling |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK11150452.8T DK2314300T3 (da) | 2006-11-03 | 2007-11-05 | Populationer af blandede celler til vævsreparation og separationsteknik til cellebehandling |
Country Status (10)
Country | Link |
---|---|
US (5) | US7871605B2 (da) |
EP (3) | EP2465514A1 (da) |
JP (4) | JP5537153B2 (da) |
AT (1) | ATE496627T1 (da) |
AU (1) | AU2007314299B2 (da) |
CA (2) | CA2668330C (da) |
DE (1) | DE602007012290D1 (da) |
DK (2) | DK2314300T3 (da) |
ES (2) | ES2441560T3 (da) |
WO (1) | WO2008054825A2 (da) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11243494B2 (en) | 2002-07-31 | 2022-02-08 | Abs Global, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
US7699767B2 (en) | 2002-07-31 | 2010-04-20 | Arryx, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
DE202007002538U1 (de) * | 2007-02-21 | 2007-06-06 | Krebs, Torsten | Begasungsvorrichtung und -system |
EP2578677A1 (en) * | 2007-08-09 | 2013-04-10 | Genzyme Corporation | Method of treating autoimmune disease with mesenchymal stem cells |
MX2011001730A (es) * | 2008-08-14 | 2011-03-24 | Osiris Therapeutics Inc | Composiciones purificadas de celulas madre mesenquimales y metodos para purificar composiciones de celulas madre mesenquimales. |
WO2010069320A2 (en) | 2008-12-19 | 2010-06-24 | Stobbe Tech A/S | Biopharmaceutical plant in a column |
NZ599596A (en) * | 2009-11-12 | 2014-01-31 | Tengion Inc | Rational design of regenerative medicine products |
US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
EP2579882A1 (en) | 2010-06-10 | 2013-04-17 | Aastrom Biosciences, Inc. | Compositions and methods of treating no-option critical limb ischemia (cli) |
US20120087933A1 (en) * | 2010-10-08 | 2012-04-12 | Samson Tom | Enhanced msc preparations |
US10908066B2 (en) | 2010-11-16 | 2021-02-02 | 1087 Systems, Inc. | Use of vibrational spectroscopy for microfluidic liquid measurement |
CN108342350A (zh) | 2011-04-15 | 2018-07-31 | 普拉里斯坦有限公司 | 收获细胞的方法和系统 |
US8834928B1 (en) | 2011-05-16 | 2014-09-16 | Musculoskeletal Transplant Foundation | Tissue-derived tissugenic implants, and methods of fabricating and using same |
WO2012159042A1 (en) | 2011-05-18 | 2012-11-22 | Aastrom Biosciences, Inc. | Mesenchymal stromal cell populations and methods of making same |
US9642897B2 (en) | 2011-09-13 | 2017-05-09 | The University Of Sydney | Treatment of bone diseases |
US20150086520A1 (en) * | 2012-03-23 | 2015-03-26 | Aastrom Biosciences, Inc. | Cell Compositions and Methods of Using Same |
US20140099292A1 (en) * | 2012-03-23 | 2014-04-10 | Aastrom Biosciences, Inc. | CD14+ Cell Compositions and Methods of Using Same |
US8927278B2 (en) * | 2012-09-10 | 2015-01-06 | National Health Research Institutes | Method for generating immunomodulatory cells, the cells prepared therefrom, and use thereof |
WO2014089397A1 (en) | 2012-12-06 | 2014-06-12 | Aastrom Biosciences, Inc. | Compositions and methods of treating and preventing pulmonary fibrosis |
US8859007B2 (en) * | 2013-01-13 | 2014-10-14 | Theracell, Inc. | Oxygenated demineralized bone matrix for bone growth |
US8961904B2 (en) | 2013-07-16 | 2015-02-24 | Premium Genetics (Uk) Ltd. | Microfluidic chip |
EP3027235A1 (en) | 2013-07-30 | 2016-06-08 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
US11796449B2 (en) | 2013-10-30 | 2023-10-24 | Abs Global, Inc. | Microfluidic system and method with focused energy apparatus |
JP6437261B2 (ja) * | 2014-09-26 | 2018-12-12 | Phcホールディングス株式会社 | 液体貯留ユニット及び分注システム |
WO2016123117A1 (en) * | 2015-01-26 | 2016-08-04 | Fate Therapeutics, Inc. | Cells with increased immuno-regulatory properties and methods for their use and manufacture |
EP4137798A1 (en) | 2015-02-19 | 2023-02-22 | 1087 Systems, Inc. | Scanning infrared measurement system |
US10531957B2 (en) | 2015-05-21 | 2020-01-14 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
WO2017015320A1 (en) | 2015-07-21 | 2017-01-26 | Children's Medical Center Corporation | Pd-l1 expressing hematopoietic stem cells and uses |
US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
WO2017139576A1 (en) * | 2016-02-12 | 2017-08-17 | Bluebird Bio, Inc. | Vcn enhancer compositions and methods of using the same |
US11326183B2 (en) | 2016-02-12 | 2022-05-10 | Bluebird Bio, Inc. | VCN enhancer compositions and methods of using the same |
EP3531663B1 (en) | 2016-10-31 | 2023-06-21 | Huawei Technologies Co., Ltd. | Call processing method, terminal, and system |
WO2019060708A1 (en) | 2017-09-22 | 2019-03-28 | The Children's Medical Center Corporation | TREATMENT OF TYPE 1 DIABETES AND AUTOIMMUNE DISEASES OR DISORDERS |
US11331670B2 (en) | 2018-05-23 | 2022-05-17 | Abs Global, Inc. | Systems and methods for particle focusing in microchannels |
US20200054788A1 (en) * | 2018-08-17 | 2020-02-20 | Vivex Biomedical, Inc. | Infused particles |
WO2020123524A1 (en) * | 2018-12-11 | 2020-06-18 | Erbi Biosystems, Inc. | Methods of manufacturing cell based products using small volume perfusion processes |
US11889830B2 (en) | 2019-04-18 | 2024-02-06 | Abs Global, Inc. | System and process for continuous addition of cryoprotectant |
US11628439B2 (en) | 2020-01-13 | 2023-04-18 | Abs Global, Inc. | Single-sheath microfluidic chip |
CN114457014B (zh) * | 2021-12-15 | 2024-05-17 | 南京医科大学 | 骨痂巨噬细胞分离用组合试剂及其应用 |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839292B1 (en) | 1987-09-11 | 1994-09-13 | Joseph G Cremonese | Cell culture flask utilizing membrane barrier |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5763266A (en) | 1989-06-15 | 1998-06-09 | The Regents Of The University Of Michigan | Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells |
US5635386A (en) | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
US5437994A (en) | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5605822A (en) | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US6326198B1 (en) | 1990-06-14 | 2001-12-04 | Regents Of The University Of Michigan | Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5811094A (en) | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
US5985653A (en) | 1995-06-07 | 1999-11-16 | Aastrom Biosciences, Inc. | Incubator apparatus for use in a system for maintaining and growing biological cells |
US5688687A (en) | 1995-06-07 | 1997-11-18 | Aastrom Biosciences, Inc. | Bioreactor for mammalian cell growth and maintenance |
US6228635B1 (en) | 1995-06-07 | 2001-05-08 | Aastrom Bioscience, Inc. | Portable cell growth cassette for use in maintaining and growing biological cells |
US6238908B1 (en) | 1995-06-07 | 2001-05-29 | Aastrom Biosciences, Inc. | Apparatus and method for maintaining and growth biological cells |
US6096532A (en) | 1995-06-07 | 2000-08-01 | Aastrom Biosciences, Inc. | Processor apparatus for use in a system for maintaining and growing biological cells |
AU731468B2 (en) | 1996-04-19 | 2001-03-29 | Mesoblast International Sarl | Regeneration and augmentation of bone using mesenchymal stem cells |
ATE307195T1 (de) | 1997-07-14 | 2005-11-15 | Osiris Therapeutics Inc | Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen |
AU9231998A (en) | 1997-09-20 | 1999-04-12 | Osiris Therapeutics, Inc. | Antigen presenting mesenchymal stem cells |
US20020034819A1 (en) | 1998-02-23 | 2002-03-21 | Alan K. Smith | Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses |
US6676937B1 (en) | 1998-03-09 | 2004-01-13 | Caritas St. Elizabeth's Medical Center Of Boston Inc. | Compositions and methods for modulating vascularization |
ATE286118T1 (de) | 1998-03-13 | 2005-01-15 | Osiris Therapeutics Inc | Anwendungen für humane nicht autologe, mesenchymale stammzellen |
DE69929681T2 (de) | 1998-03-18 | 2006-10-26 | Osiris Therapeutics, Inc. | Mesenchymale stammzellen für die prävention und behandlung von immunantworten bei transplantationen |
US6368636B1 (en) | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
DE69910362T2 (de) | 1998-04-03 | 2004-06-24 | Osiris Therapeutics, Inc. | Anwendung der mesenchymalen stammzellen als immunsuppressiva |
EP1082410B1 (en) | 1998-05-29 | 2007-08-01 | Osiris Therapeutics, Inc. | Human cd45+ and/or fibroblast + mesenchymal stem cells |
US6777231B1 (en) | 1999-03-10 | 2004-08-17 | The Regents Of The University Of California | Adipose-derived stem cells and lattices |
US7097832B1 (en) | 1999-03-30 | 2006-08-29 | Myocardial Therapeutics, Inc. | Intramyocardial injection of autologous bone marrow |
AUPQ147799A0 (en) | 1999-07-07 | 1999-07-29 | Medvet Science Pty. Ltd. | Mesenchymal precursor cell |
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
JP2004516242A (ja) | 2000-07-26 | 2004-06-03 | サイムド ライフ システムズ, インコーポレイテッド | 心筋および骨格筋の虚血組織に骨髄由来の細胞移植をすることによる、治療を目的とした血管形成 |
US20050226857A1 (en) * | 2001-06-01 | 2005-10-13 | Xcyte Therapies, Inc. | T cell therapy for the treatment of cachexia and chronic diseases |
JP2004528042A (ja) * | 2001-06-01 | 2004-09-16 | エクサイト セラピーズ, インコーポレイテッド | T細胞誘導性組織修復および再生 |
US9969980B2 (en) * | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
US20030170238A1 (en) * | 2002-03-07 | 2003-09-11 | Gruenberg Micheal L. | Re-activated T-cells for adoptive immunotherapy |
ES2313805B1 (es) * | 2004-10-04 | 2009-12-23 | Cellerix, S.L. | Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral. |
DE102004055615A1 (de) * | 2004-11-16 | 2006-05-18 | Universitätsklinikum Hamburg-Eppendorf | In vitro aus Knochenmarkstammzellen differenzierte Retina-spezifische Zellen, ihre Herstellung und Verwendung |
US20080267972A1 (en) * | 2005-02-10 | 2008-10-30 | Invitrogen Corporation | Donor Lymphocyte Infusion of T Cells For the Treatment of Cancer |
-
2007
- 2007-11-05 EP EP20110194945 patent/EP2465514A1/en not_active Withdrawn
- 2007-11-05 US US11/983,008 patent/US7871605B2/en active Active
- 2007-11-05 EP EP11150452.8A patent/EP2314300B1/en active Active
- 2007-11-05 AT AT07867360T patent/ATE496627T1/de active
- 2007-11-05 AU AU2007314299A patent/AU2007314299B2/en not_active Ceased
- 2007-11-05 EP EP07867360A patent/EP2086556B1/en active Active
- 2007-11-05 DE DE602007012290T patent/DE602007012290D1/de active Active
- 2007-11-05 CA CA2668330A patent/CA2668330C/en active Active
- 2007-11-05 CA CA2913024A patent/CA2913024A1/en not_active Abandoned
- 2007-11-05 ES ES11150452.8T patent/ES2441560T3/es active Active
- 2007-11-05 DK DK11150452.8T patent/DK2314300T3/da active
- 2007-11-05 DK DK07867360.5T patent/DK2086556T3/da active
- 2007-11-05 JP JP2009535351A patent/JP5537153B2/ja active Active
- 2007-11-05 WO PCT/US2007/023302 patent/WO2008054825A2/en active Application Filing
- 2007-11-05 ES ES07867360T patent/ES2362150T3/es active Active
-
2010
- 2010-12-07 US US12/962,378 patent/US8394631B2/en active Active
- 2010-12-07 US US12/962,355 patent/US8158122B2/en active Active
-
2013
- 2013-03-04 US US13/784,066 patent/US9415071B2/en active Active
- 2013-07-16 JP JP2013147587A patent/JP5767672B2/ja active Active
-
2015
- 2015-02-24 JP JP2015033640A patent/JP6246754B2/ja active Active
-
2016
- 2016-07-12 US US15/208,488 patent/US20160317584A1/en not_active Abandoned
-
2017
- 2017-05-19 JP JP2017099578A patent/JP2017141298A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2314300T3 (da) | Populationer af blandede celler til vævsreparation og separationsteknik til cellebehandling | |
Huang et al. | Long-term dynamic loading improves the mechanical properties of chondrogenic mesenchymal stem cell-laden hydrogels | |
UA92157C2 (ru) | Способ продуцирования гормона роста | |
DK1576182T4 (da) | Produktkvalitetsforbedring ved fremgangsmåde med dyrkning af pattedyreceller til proteinfremstilling | |
DK1483369T3 (da) | Fuglecellelinier til fremstiling af stoffer af interesse | |
SG150567A1 (en) | Pluripotent stem cell growing method | |
RU2010103046A (ru) | Культивирование отдельных плюрипотентных стволовых клеток | |
WO2006044594A3 (en) | Methods for culturing mammalian taste cells | |
AU2003261308A8 (en) | Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays | |
RU2019138327A (ru) | Способы перфузионного культивирования и их применения | |
WO2010020876A3 (en) | Cell culture method to form aggregates | |
WO2003010304A3 (de) | Verfahren zur herstellung isolierter zellkulturen, kulturmedium zur kultivierung von zellkulturen und zellkultur | |
DK1543147T4 (da) | Fremgangsmåde til påvisning af methicillin-resistente Staphylococcus aureus | |
DE602006014534D1 (de) | Herstellung und verwendung von basalmembranpartikeln | |
WO2004033616A8 (de) | Einrichtung zur kultivierung von zellen, insbesondere menschlicher oder tierischer zellen | |
EP3950918A4 (en) | CELL CULTURE SCAFFOLD MATERIAL, CELL CULTURE VESSEL, CELL CULTURE FIBER AND METHODS FOR CELL CULTIVATION | |
WO2005054447A3 (en) | Müller stem cells | |
IL179318A (en) | Methods for cultivating stem cells, cell cultures and the use of an egg for the cultivation of the stem cells | |
WO2005033262A3 (fr) | Procede et dispositif de culture de cellules vivantes par couplage d'un recipient bioreacteur avec un automate de selection | |
WO2002064811A3 (fr) | Procede pour produire des proteines recombinantes, marquees par au moins un isotope | |
WO2006121848A3 (en) | Method for the isolation of spiroplasma in mammals | |
EP4119193A4 (en) | METHOD FOR CULTIVATING CELLS FROM EPITHELIAL TISSUE, AND COMPOSITION CONTAINING CELLS CULTIVATED BY SAID CULTURE METHOD | |
EP2399987A4 (en) | CULTURE MEDIUM AND METHOD FOR INDUCING DIFFERENTIATION IN BONE CELLS | |
MX2007005210A (es) | Medio de cultivo de celula libre de suero para las celulas de los mamiferos. | |
WO2006135676A3 (en) | Method for isolating potential antibiotic microorganisms |